Expanding Immunotherapy Options for Bladder Cancer: Commentary on: Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
作者信息
Lavoie Jean-Michel, Bidnur Samir, Black Peter C, Eigl Bernhard J
机构信息
British Columbia Cancer Agency, Vancouver, BC.
Vancouver Prostate Centre, University of British Columbia, Vancouver, BC.
出版信息
Urology. 2017 Aug;106:1-2. doi: 10.1016/j.urology.2017.04.001. Epub 2017 Apr 25.
Abstract
摘要
Zotero 插件